FDA Bans Electrical Shock Devices Used on the Mentally Disabled
Ban takes effect 30 days after publication in the Federal Register.
FDA
FDA Approves Wakix For Excessive Daytime Sleepiness In Adults With Narcolepsy
The Food and Drug Administration (FDA) approved Wakix for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.
FDA Approves Sale of Low-Nicotine Cigarettes
Nicotine content of the 2 newly approved cigarettes is less than 1 mg per cigarette.
FDA Clears First Fully Disposable Duodenoscope
This approval follows the recent approvals of duodenoscopes with a disposable elevator channel and endcaps.
FDA Recommends Improvements to Breast Implant Safety Information
The FDA released a draft guidance to help women have access to information about the risks and benefits of breast implants.
Zantac Recalled by Sanofi
FDA has warned that some versions of the drug contain low levels of N-nitrosodimethylamine.
‘Miracle Mineral Solution’ Is No Miracle Cure, FDA Warns
When mixed, the solution develops into a dangerous bleach.
FDA Warns CBD Product Maker About False Claims
Agency says unproven claims about CBD products could lead consumers to delay medical care.
The FDA Seeks Your Feedback on New Measure for Fixed-Quantity Blister Packaging for Opioids
The US Food and Drug Administration is seeking feedback from healthcare professionals on its proposal to offer fixed-quantity blister packaging for a select number of opioid medications.
FDA Approves Venetoclax for Chronic Lymphocytic Leukemia
In randomized trial, drug demonstrated statistically significant improvement in progression-free survival.
Next post in Hematology/Oncology Information Center
